Home › NDC Lookup › RxCUI directory › RxCUI 1739770

Brivaracetam 100 MG Oral Tablet [Briviact] — RxCUI 1739770

RxNorm drug concept · Semantic branded drug
RxCUI 1739770 Semantic branded drug · SBD ● Current RxNorm concept 7 FDA products 13 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1739770
Official nameBrivaracetam 100 MG Oral Tablet [Briviact]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asBriviact 100 MG Oral Tablet
FDA products mapped7
Package NDCs mapped13
Reported Medicaid activity (SDUD)174,041 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Brivaracetam Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Briviact injection is used when you temporarily can't swallow tablets or liquid — for example, if you're in the hospital, recovering from a procedure, or having trouble swallowing....
  • Why am I getting brivaracetam as an injection instead of a pill?
  • The most common ones are drowsiness, dizziness, fatigue, and nausea. These tend to be most noticeable early in treatment. Most people manage them fine, but you should avoid driving...
  • What side effects are most common and should I be worried about them?
📖 Read our full Brivaracetam Injection guide →

🕸️ Concept Web — How Brivaracetam 100 MG Oral Tablet [Briviact] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Brivaracetam 100 MG Oral Tablet [Briviact] RxCUI 1739770

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Brivaracetam 1739745
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Briviact 1739750
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Brivaracetam Oral Tablet 1739760
    • Brivaracetam Oral Product 1739758
    • Brivaracetam Pill 1739759
    • Brivaracetam Oral Tablet [Briviact] 1739763
    • Briviact Oral Product 1739764
    • Briviact Pill 1739765
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Brivaracetam 100 MG Oral Tablet SCD · 1739768
  • Brivaracetam 100 MG SCDC · 1739767
  • Brivaracetam Oral Tablet SCDF · 1739760
  • Brivaracetam Oral Product SCDG · 1739758
  • Brivaracetam Pill SCDG · 1739759

Brand-Name Concepts

  • Brivaracetam 100 MG [Briviact] SBDC · 1739769
  • Brivaracetam Oral Tablet [Briviact] SBDF · 1739763
  • Briviact Oral Product SBDG · 1739764
  • Briviact Pill SBDG · 1739765
  • Briviact BN · 1739750

📦 FDA Products & Package NDCs

7 products · 13 package NDCs
13 package NDCs map to RxCUI 1739770 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
50474-0370-66 1 BOTTLE in 1 CARTON (50474-370-66) / 60 TABLET, FILM COATE... Briviact UCB, Inc. 2016-05-12
50474-0470-09 100 BLISTER PACK in 1 CARTON (50474-470-09) / 1 TABLET, FIL... Briviact UCB, Inc. 2016-05-12
50474-0470-14 1 BLISTER PACK in 1 CARTON (50474-470-14) / 14 TABLET, FILM... Briviact UCB, Inc. 2016-05-12
50474-0470-66 1 BOTTLE in 1 CARTON (50474-470-66) / 60 TABLET, FILM COATE... Briviact UCB, Inc. 2016-05-12
50474-0570-09 100 BLISTER PACK in 1 CARTON (50474-570-09) / 1 TABLET, FIL... Briviact UCB, Inc. 2016-05-12
50474-0570-14 1 BLISTER PACK in 1 CARTON (50474-570-14) / 14 TABLET, FILM... Briviact UCB, Inc. 2016-05-12
50474-0570-66 1 BOTTLE in 1 CARTON (50474-570-66) / 60 TABLET, FILM COATE... Briviact UCB, Inc. 2016-05-12
50474-0670-66 1 BOTTLE in 1 CARTON (50474-670-66) / 60 TABLET, FILM COATE... Briviact UCB, Inc. 2016-05-12
50474-0770-09 100 BLISTER PACK in 1 CARTON (50474-770-09) / 1 TABLET, FIL... Briviact UCB, Inc. 2016-05-12
50474-0770-14 1 BLISTER PACK in 1 CARTON (50474-770-14) / 14 TABLET, FILM... Briviact UCB, Inc. 2016-05-12
50474-0770-66 1 BOTTLE in 1 CARTON (50474-770-66) / 60 TABLET, FILM COATE... Briviact UCB, Inc. 2016-05-12
50474-0870-15 1 BOTTLE in 1 CARTON (50474-870-15) / 300 mL in 1 BOTTLE Briviact UCB, Inc. 2016-05-12
50474-0970-75 10 VIAL, GLASS in 1 CARTON (50474-970-75) / 5 mL in 1 VIAL,... Briviact UCB, Inc. 2016-05-12
Observed labelers: UCB, Inc. (13) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.